Added to YB: 2026-01-21
Pitch date: 2026-01-19
IRIX [neutral]
IRIDEX Corporation
-2.08%
current return
Author Info
Byron Street Research is an investment publication featuring a weekly event-driven idea generator, write-ups modeled in the familiar format of sell-side equity research reports, and performance reviews structured as traditional fund factsheets. Sign up for the newsletter.
Company Info
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Market Cap
$24.6M
Pitch Price
$1.44
Price Target
N/A
Dividend
N/A
EV/EBITDA
-17.31
P/E
-4.72
EV/Sales
0.59
Sector
Health Care Equipment and Supplies
Category
turnaround
Catalyst Watch - IRIDEX Corporation
IRIX (update): Health care equipment co reported Q4 2025 prelim results w/ $14.6-14.8M rev vs $12.7M prior year (15-17% YoY growth). 5th consecutive quarter YoY growth, positive Q4 cash flow, expects positive adj EBITDA for FY25. Strengthened position via cost cuts, margin expansion, commercial efficiency.
Read full article (1 min)